top of page

Aalto Bio Reagents
-
Founded in 1978
-
Market leader in the development of proteins and antibodies for new and emerging diseases eg. Chikungunya , Dengue , Zika , Sars , COVID-19 and VEEV virus
-
Custom manufacture of new recombinant antigens
-
Routine manufacture of bulk antigens and antibodies
-
Full raw material menu for chemiluminescence platforms
-
Europes largest provider of bulk disease state plasma for controls
-
Joined the Biosynth Group to form the biologics division in May 2022
Aalto's Latest News
bottom of page